全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Hybrid Modality Fusion of Planar Scintigrams and CT Topograms to Localize Sentinel Lymph Nodes in Breast Lymphoscintigraphy: Technical Description and Phantom Studies

DOI: 10.1155/2011/298102

Full-Text   Cite this paper   Add to My Lib

Abstract:

Lymphoscintigraphy is a nuclear medicine procedure that is used to detect sentinel lymph nodes (SLNs). This project sought to investigate fusion of planar scintigrams with CT topograms as a means of improving the anatomic reference for the SLN localization. Heretofore, the most common lymphoscintigraphy localization method has been backlighting with a 57Co sheet source. Currently, the most precise method of localization through hybrid SPECT/CT increases the patient absorbed dose by a factor of 34 to 585 (depending on the specific CT technique factors) over the conventional 57Co backlighting. The new approach described herein also uses a SPECT/CT scanner, which provides mechanically aligned planar scintigram and CT topogram data sets, but only increases the dose by a factor of two over that from 57Co backlighting. Planar nuclear medicine image fusion with CT topograms has been proven feasible and offers a clinically suitable compromise between improved anatomic details and minimally increased radiation dose. 1. Introduction An essential step in the procedure for sentinel lymph node (SLN) biopsy is to locate the first-echelon node of the drainage basin. Lymphoscintigraphy is a minimally invasive diagnostic tool for mapping the SLN. After injecting the patient with sulfur colloid radiolabeled with in locations proximal to a tumor site and waiting for lymphatic drainage to occur, the lymphatic drainage pathway from the primary injection site may be imaged with a gamma camera [1]. Interpretation of lymphoscintigrams is hindered by the absence of anatomical landmarks in the scintigraphy image. To partly cope with this limitation, it is customary to acquire additional transmission images via a backlighting 57Co sheet source in order to facilitate the anatomic localization of the nodes seen on the scintigraphy image. While the backlighting imaging technique creates an outline of the patient’s body, it depicts no internal landmarks. The introduction of hybrid single photon emission computed tomography with computed tomography (SPECT/CT) systems into clinical practice presents an opportunity to improve the spatial localization in lymphoscintigraphy [2]. Improvement in the localization technique could potentially help the surgeon prepare for sentinel node biopsy (SNB) operations, for example, when SLNs lie in the internal mammary chain where bony anatomy necessitates pinpointing the location of a node before incision. Single photon emission computed tomography and computed tomography image fusion (known as SPECT/CT) provides accurate three-dimensional (3D)

References

[1]  B. R. Krynyckyi, C. K. Kim, M. R. Goyenechea, P. T. Chan, Z.-Y. Zhang, and J. Machac, “Clinical breast lymphoscintigraphy: optimal techniques for performing studies, image atlas, and analysis of images,” Radiographics, vol. 24, no. 1, pp. 121–139, 2004.
[2]  I. M. C. Van der Ploeg, R. A. Valdés Olmos, B. B. R. Kroon, and O. E. Nieweg, “The hybrid SPECT/CT as an additional lymphatic mapping tool in patients with breast cancer,” World Journal of Surgery, vol. 32, no. 9, pp. 1930–1934, 2008.
[3]  B. R. Krynyckyi, M. Miner, J. M. Ragonese, M. Firestone, C. K. Kim, and J. Machac, “Technical aspects of performing lymphoscintigraphy: optimization of methods used to obtain images,” Clinical Nuclear Medicine, vol. 25, no. 12, pp. 978–985, 2000.
[4]  M. V. Mar, R. L. Dickinson, W. D. Erwin, and R. E. Wendt III, “Optimal flood source activity and acquisition time for lymphoscintigraphy localization images,” Journal of Nuclear Medicine Technology, vol. 36, no. 2, pp. 82–87, 2008.
[5]  B. R. Krynyckyi, H. Chun, H. K. Hyun, Y. Eskandar, C. K. Kim, and J. Machac, “Factors affecting visualization rates of internal mammary sentinel nodes during lymphoscintigraphy,” Journal of Nuclear Medicine, vol. 44, no. 9, pp. 1387–1393, 2003.
[6]  B. R. Krynyckyi, C. K. Kim, M. Goyenechea, and J. Machac, “Methods to outline the patient during lymphoscintigraphy,” Journal of Nuclear Medicine, vol. 44, no. 6, pp. 992–993, 2003.
[7]  B. R. Krynyckyi, S. Sata, I. Zolty, C. K. Kim, and K. Kne?aurek, “Reducing exposure from sources during breast lymphoscintigraphy by optimizing energy windows and other suggested enhancements of acquisition and the display of images,” Journal of Nuclear Medicine Technology, vol. 32, no. 4, pp. 198–205, 2004.
[8]  E. Clarke, A. Notghi, and K. Harding, “Improved body-outline imaging technique for localization of sentinel lymph nodes in breast surgery,” Journal of Nuclear Medicine, vol. 43, no. 9, pp. 1181–1183, 2002.
[9]  B. H. Hasegawa, E. L. Gingold, S. M. Reilly, S.-C. Liew, and C. E. Cann, “Description of a simultaneous emission-transmission CT system,” in Medical Imaging IV: Image Formation, vol. 1231 of Proceedings of SPIE, Newport Beach, Calif, USA, February 1990.
[10]  T. Beyer, D. W. Townsend, and D. W. Townsend, “A combined PET/CT scanner for clinical oncology,” Journal of Nuclear Medicine, vol. 41, no. 8, pp. 1369–1379, 2000.
[11]  D. B. Husarik and H. C. Steinert, “Single-photon emission computed tomography/computed tomographyfor sentinel node mapping in breast cancer,” Seminars in Nuclear Medicine, vol. 37, no. 1, pp. 29–33, 2007.
[12]  H. Lerman, G. Lievshitz, O. Zak, U. Metser, S. Schneebaum, and E. Even-Sapir, “Improved sentinel node identification by SPECT/CT in overweight patients with breast cancer,” Journal of Nuclear Medicine, vol. 48, no. 2, pp. 201–206, 2007.
[13]  H. Lerman, U. Metser, G. Lievshitz, F. Sperber, S. Shneebaum, and E. Even-Sapir, “Lymphoscintigraphic sentinel node identification in patients with breast cancer: the role of SPECT-CT,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 33, no. 3, pp. 329–337, 2006.
[14]  M. V. Mar, S. A. Miller, E. E. Kim, and H. A. Macapinlac, “Evaluation and localization of lymphatic drainage and sentinel lymph nodes in patients with head and neck melanomas by hybrid SPECT/CT lymphoscintigraphic imaging,” Journal of Nuclear Medicine Technology, vol. 35, no. 1, pp. 10–16, 2007.
[15]  B. A. E. Kapteijn, O. E. Nieweg, S. H. Muller, I. H. Liem, C. A. Hoefnagel, E. J. TH. Rutgers, and B. B. R. Kroon, “Validation of gamma probe detection of the sentinel node in melanoma,” Journal of Nuclear Medicine, vol. 38, no. 3, pp. 362–366, 1997.
[16]  T. Rink, T. Heuser, H. Fitz, H.-J. Schroth, E. Weller, and H. H. Zippel, “Lymphoscintigraphic sentinel node imaging and gamma probe detection in breast cancer with Tc-99m nanocolloidal albumin: results of an optimized protocol,” Clinical Nuclear Medicine, vol. 26, no. 4, pp. 293–298, 2001.
[17]  C. De Cicco, M. Cremonesi, and M. Cremonesi, “Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer,” Journal of Nuclear Medicine, vol. 39, no. 12, pp. 2080–2084, 1998.
[18]  J. C. O'Daniel, D. M. Stevens, and D. D. Cody, “Reducing radiation exposure from survey CT scans,” American Journal of Roentgenology, vol. 185, no. 2, pp. 509–515, 2005.
[19]  D. Hart and B. Wall, “Report No. National Radiological Protection Board (NRPB) Report W4,” 2002.
[20]  M. F. McNitt-Gray, “AAPM/RSNA physics tutorialfor residents: topics in CT: radiation dose in CT,” Radiographics, vol. 22, no. 6, pp. 1541–1553, 2002.
[21]  C. H. McCollough, D. D. Cody, S. Edyvean, et al., “The measurement, reporting, and management of radiation dose in CT,” AAPM Report 96, 2008.
[22]  “European Guidelines of Quality Criteria for Computed Tomography,” vol. 2007, May 1999, http://www.drs.dk/guidelines/ct/quality/htmlindex.htm.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413